Back

Cardiovascular magnetic resonance vs. echocardiography for assessing baseline cardiovascular reserve in patients undergoing CAR-T therapy

29 August 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Cardio-immuno-oncology Cardio-Oncology ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mrs Begona Aumente Rodriguez

Complejo Asistencial Universitario de Salamanca, Salamanca (Spain)

5 More presentations in this session

Presentation thumbnail
Increased cardiovascular risk and cardiac dysfunction in cancer survivors from UK Biobank
Ms G. Andriamiadana (London, GB)
Abstract Slides Video
Presentation thumbnail
Longitudinal changes in right ventricular function in breast cancer patients undergoing cardiotoxic chemotherapy
Doctor E. Guerra (Mexico City, MX) Doctor N. Espinola-Zavaleta (Mexico City, MX)
Abstract Slides Video
Presentation thumbnail
Treatment response in light chain cardiac amyloidosis improves left ventricular arterial coupling.
Associate Professor A. Briasoulis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Discovery of novel imaging biomarkers for cardiotoxicity in a prospective longitudinal study of cancer patients receiving anthracyclines and chest radiotherapy
Doctor G. Ntentas (London, GB)
Abstract Slides Video
Presentation thumbnail
MicroRNA signatures and machine learning models for predicting cardiotoxicity in HER2 positive breast cancer patients
Doctor E. Oikonomou (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Cardio-immuno-oncology

The Event

Event poster

ESC Congress 2025

29 August 2025 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular complications of chimeric antigen receptor (CAR)-T cell therapy
thumbnail
Congress Presentation
Patients with non-Hodgkin's lymphoma treated with CAR T-cell therapy are at risk of impaired left ventricular function
thumbnail
Congress Presentation
Low cardiovascular event rates in patients treated with CAR T-cells: real-world outcomes from two independent cohorts

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources